Abstract: Provided is uses of SAA1?/?(1.5/1.5) homozygote in prognosis and/diagnosis of liver cirrhosis, and in preparation of a reagent for liver cirrhosis prognosis and/or liver cirrhosis diagnosis. Recognition of liver cirrhosis susceptible populations can be achieved by detection of human SAA1?/? homozygote and non-SAA1?/? homozygote through real-time fluorescence quantitative allele specific PCR.
Type:
Grant
Filed:
March 19, 2012
Date of Patent:
July 18, 2017
Assignee:
DIASYS DIAGNOSTIC SYSTEMS (SHANGHAI) CO., LTD.
Inventors:
Rongfang Wang, Jun Wu, Yan Zhang, Zhenbin Qian